BMX and Familial prostate cancer: BMX-IN-1 has been shown to inhibit BMX catalytic activity and decrease BMX protein levels in prostate cancer cells [44] while Guo et al. [45] developed the small molecule inhibitor CTN06 that can induce autophagy and apoptosis, inhibit the growth and migration of prostate cancer cells and downregulate oncogenic-related genes.